ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: PP02

Living and Adjusting to a Diagnosis of Rheumatoid Arthritis (RA) with an Interdisciplinary Team

Marie-Claude Beaulieu1, Julie Robindaine 2, Hélène Tremblay 2, Stéphanie Demers Dubuc 2, Patrick Liang 3 and France Gervais 2, 1, 2Quebec, Canada, 3Universite de Sherbrooke, Quebec, Canada

Meeting: 2019 ACR/ARP Annual Meeting

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Patient Perspectives Poster Session

Session Type: Poster Session (Sunday)

Session Time: 11:30AM-1:30PM

Background/Purpose: RA affects all age groups and all occupational settings. I was diagnosed at age 58, while I was still very active at work, at sports and as a grandmother. I had to adapt to this new reality in several ways. Initially, the presentation was atypical (polymyalgia-like), and the disease was difficult to control with steroids. During steroid tapering, severe limitations in my hands, wrists, shoulders, ankles and feet associated with subtle hand synovitis (ultra sound exam negative once) made my rheumatologist suspect RA despite normal biomarkers. I started treatment with a combination of hydroxychloroquine and methotrexate injection, failed an anti-TNF and finally got sustained improvement with the addition of tofacitinib.

Treatment: I can attest how much an interdisciplinary team helps: rheumatologist, nurse, occupational therapist (OT) and physical therapist (PT) working with each other. Their support was especially important at the beginning of my disease, with the possibility to phone and ask questions to the specialized nurse to reduce my stress and improve my adherence to treatment. To overcome physical limitations, an OT provided orthotics for my hands, and several useful tips for energy conservation and activities of daily living. A PT gave me valuable tips and exercises to do at home. It would be particularly helpful if all patients should have access to these services early in their disease, although a supporting team may be important over all the disease stages, and particularly during flares or loss of efficacy of drugs. Our Faculty of Medicine in Sherbrooke developed a special teaching clinic “CURE” (OT and PT services) to give low-cost access to these services for patients without insurance. When receiving a diagnosis of arthritis, a grieving process ensues, a reorganization of daily activities is required and a lot of resilience to accept these changes is needed! I had to stop working temporarily and then returned to work progressively with adaptations and changes. The support of my rheumatologist was most important in this process.

Maintenance: My rheumatologist offered several effective treatments to slow down the progression of the disease, and we found together the winning combination (with trial and error). The availability and support from the interdisciplinary team, family and co-workers is very important, as there are good and bad periods. I need to keep hope, continue to be active, allow for rest periods, eat healthy and take the medication despite sometimes annoying side effects. Daily mindfulness meditation (offered to interested patients in our clinic) helps me a lot.

Quality of Life: It is very encouraging to regain control of one’s life through better control of the disease and to feel better and lead an almost normal life. However, I have to remain vigilant and be careful of infections since my immune system is weaker with the medication. The initial frequent consultations, regular check-ups, discouragement periods over my limitations and the frequent medication adjustments made me realize the importance of working as a team where the patient is a partner in care. Information about the disease and its treatments is important for the patient and health professionals as well.


Disclosure: M. Beaulieu, None; J. Robindaine, None; H. Tremblay, None; S. Demers Dubuc, None; P. Liang, None; F. Gervais, None.

To cite this abstract in AMA style:

Beaulieu M, Robindaine J, Tremblay H, Demers Dubuc S, Liang P, Gervais F. Living and Adjusting to a Diagnosis of Rheumatoid Arthritis (RA) with an Interdisciplinary Team [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/living-and-adjusting-to-a-diagnosis-of-rheumatoid-arthritis-ra-with-an-interdisciplinary-team/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/living-and-adjusting-to-a-diagnosis-of-rheumatoid-arthritis-ra-with-an-interdisciplinary-team/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology